AstraZeneca PLC (AZNCF) Stock Analysis | Financial Data & Charts

Investment Radar

Seven-Dimensional Value Assessment Based on 2025 Q4 Financials

加载雷达图...

加载图表中...

📊 Valuation

Key valuation metrics

EV/EBITDA (TTM)

i

Enterprise Value, EBITDA and Ratio

EV/EBIT (TTM)

i

Enterprise Value, EBIT and Ratio

EV/Sales (TTM)

i

Enterprise Value, Revenue and Ratio

P/E Ratio (TTM)

i

Market Cap, Net Income and Ratio

P/B Ratio (Quarterly)

i

Market Cap, Book Value and Ratio

FCF Yield (TTM)

i

FCF, Enterprise Value and Yield

PR Profit Ratio (PPM)

i

PE Ratio, ROE and Profit Ratio (PR = PE / ROE)

📈 Growth

Revenue, earnings, and per-share growth metrics

Revenue (Quarterly)

i

Quarterly Revenue

Revenue/Share (Quarterly)

i

Revenue Per Share

Net Income (Quarterly)

i

Quarterly Net Income

EPS (Quarterly)

i

Earnings Per Share

Gross Profit/Share (Quarterly)

i

Gross Profit Per Share

OCF/Share (Quarterly)

i

Operating Cash Flow Per Share

FCF/Share (Quarterly)

i

Free Cash Flow Per Share

Operating Leverage (YoY)

i

Change in Operating Income / Change in Revenue

💰 Profitability

Profit margins and return on equity

Gross Margin (TTM)

i

Revenue, Gross Profit and Gross Margin

Operating Margin (TTM)

i

Revenue, Operating Income and Operating Margin

Net Profit Margin (TTM)

i

Revenue, Net Income and Net Profit Margin

ROE (TTM)

i

Equity, Net Income and Return on Equity

ROA (TTM)

i

Assets, Net Income and Return on Assets

ROTCE - Return on Tangible Common Equity (TTM)

i

Net Income, Tangible Common Equity and ROTCE

OCF Margin (TTM)

i

Revenue, Operating Cash Flow and OCF Margin

FCF Margin (TTM)

i

Revenue, Free Cash Flow and FCF Margin

💵 Cash Quality

Cash flow quality and conversion metrics

OCF/NI Ratio (TTM)

i

Operating Cash Flow, Net Income and Ratio

FCF/NI Ratio (TTM)

i

Free Cash Flow, Net Income and Ratio

OCF/Capex (TTM)

i

Operating Cash Flow, Capex and Coverage Ratio

OCF/SBC (TTM)

i

Operating Cash Flow, SBC and Coverage Ratio

🛡️ Leverage & Liquidity

Debt, liquidity, and financial health

Debt/Equity (quarterly)

i

Total Debt, Total Equity and Debt/Equity Ratio

EBITDA/Net Debt (TTM)

i

EBITDA, Net Debt and Coverage Ratio

Interest Coverage (TTM)

i

EBIT, Interest Expense and Coverage Ratio

Current Ratio (quarterly)

i

Current Assets, Current Liabilities and Current Ratio

Quick Ratio (quarterly)

i

Quick Assets, Current Liabilities and Quick Ratio

Altman Z-Score

i

Financial Distress Prediction Model

⚙️ Ops & Cap Efficiency

Asset utilization, working capital, ROIC, and capital efficiency

ROIC (TTM)

i

NOPAT, Invested Capital and Return on Invested Capital

ROCE - Return on Capital Employed (TTM)

i

EBIT, Capital Employed and Return on Capital Employed

Asset Turnover (TTM)

i

Revenue, Total Assets and Turnover Ratio

CapEx/Depreciation - Investment Intensity (TTM)

i

CapEx, Depreciation and Ratio (>1=Expansion, <1=Contraction)

R&D/Gross Profit - R&D Intensity (TTM)

i

R&D Expenses, Gross Profit and Ratio

SG&A/Revenue - SG&A Efficiency (TTM)

i

SG&A Expenses, Revenue and Ratio

Cash Conversion Cycle (TTM)

i

DSO + DIO - DPO (in days)

DSO - Days Sales Outstanding (TTM)

i

Average Receivables and Days Sales Outstanding

DIO - Days Inventory Outstanding (TTM)

i

Average Inventory and Days Inventory Outstanding

DPO - Days Payables Outstanding (TTM)

i

Average Payables and Days Payables Outstanding

Goodwill/Assets (Quarterly)

i

Goodwill as % of Total Assets

🎁 Shareholder Returns

Dividends, share buybacks, dilution, and insider trading activity

Dividend Yield (TTM)

i

Dividend Per Share, Share Price and Dividend Yield

Buyback Yield (TTM)

i

Net Buyback and Buyback Yield

Buyback Yield (3 Years)

i

Net Buyback 3Y and Buyback Yield 3Y

Dilution Rate (1 Year)

i

Current Shares, 1Y Ago Shares and Dilution Rate

Dilution Rate (3 Years)

i

Current Shares, 3Y Ago Shares and Dilution Rate

SBC Offset Rate (TTM)

i

Buyback / Stock-Based Comp and SBC Ratio

Insider Activity Rate (TTM)

i

Insider Net Buying and Activity Rate

Profit Waterfall Analysis

加载图表中...

P

Profitability Margins

Gross Profit Margini

79.89%

Gross Profit = $12.38B

Revenue = $15.50B

Operating Profit Margini

19.21%

Operating Income = $2.98B

Revenue = $15.50B

EBITDA Margini

29.83%

EBITDA = $4.62B

Revenue = $15.50B

EBIT Margini

20.08%

EBIT = $2.63B

Revenue = $15.50B

Net Profit Margini

15.00%

Net Income = $2.33B

Revenue = $15.50B

Pretax Profit Margini

16.96%

EBT = $2.63B

Revenue = $15.50B

E

Operating Efficiency

Interest Coveragei

8.60x

EBIT (TTM) = $14.02B

Interest Expense (TTM) = $1.63B

6.0x

6.5x

7.0x

8.3x

8.6x

SG&A / Revenuei

36.41%

SG&A = $5.64B

Revenue = $15.50B

R&D / Revenuei

24.91%

R&D = $3.86B

Revenue = $15.50B

R

Return Metrics (TTM)

ROAi

9.44%

Net Income = $10.30B

Avg Total Assets = $109.05B

ROEi

23.03%

Net Income = $10.30B

Avg Equity = $44.73B

ROICi

16.68%

NOPAT (TTM) = $11.34B

Avg Invested Capital = $68.03B

(NOPAT = Operating Income × (1 - Effective Tax Rate))

(Avg IC = (Current IC + Year-Ago IC) / 2)

Revenue Growthi

4.11%

Current Revenue = $15.50B

Previous Revenue = $14.89B

+20.7%

+7.7%

+11.5%

+12.0%

+4.1%

Operating Cash Flow/Sharei

$9.33

Operating CF = $14.57B

Diluted Shares = 1.56B

$7.65

$8.38

$8.59

$9.70

$9.33

Comprehensive Analysis

Income Statement Items	YoY Growth	Current Quarter Value	Trend
Revenue	+4.1%	$15.50B	↑
Gross Profit	+1.8%	$12.38B, 79.89%	↑
Operating Income	+46.3%	$2.98B, 19.21%	↑
EBITDA	+4.3%	$4.62B, 29.83%	↑
EBT	+57.8%	$2.63B, 16.96%	↑
Net Income	+55.1%	$2.33B, 15.00%	↑
Diluted EPS	+55.2%	1.49	↑

加载图表中...

L

Liquidity Metrics

Current Ratioi

0.94

Attention

Total Current Assets = $28.72B

Total Current Liabilities = $30.62B

Quick Ratioi

0.72

Attention

Quick Assets = $22.17B

Total Current Liabilities = $30.62B

Cash Ratioi

0.19

Attention

Cash & Equivalents = $5.74B

Total Current Liabilities = $30.62B

Cash Ratio = (Cash + Short-term Investments) / Current Liabilities

L

Leverage Metrics

Debt to Equityi

0.61

Normal

Total Debt = $29.62B

Total Equity = $48.67B

Liabilities to Assetsi

57.3%

Normal

Total Liabilities = $65.36B

Total Assets = $114.07B

Equity Multiplieri

2.34

Normal

Total Assets = $114.07B

Total Equity = $48.67B

E

Efficiency Metrics

Asset Turnoveri

0.54

Normal

Revenue (TTM) = $58.74B

Avg Total Assets = $109.05B

Inventory Turnoveri

1.63

Attention

COGS (TTM) = $10.69B

Avg Inventory = $6.58B

Receivables Turnoveri

3.98

Attention

Revenue (TTM) = $58.74B

Avg Receivables = $14.76B

S

Solvency Metrics

Interest Coveragei

8.60

Healthy

EBIT (TTM) = $14.02B

Interest Expense (TTM) = $1.63B

Net Debt to EBITDAiNet Debt/EBITDA

1.21

Normal

Net Debt = $23.91B

EBITDA (TTM) = $19.76B

Debt Service Coveragei

4.11

Healthy

Operating CF (TTM) = $14.57B

Debt Service = $3.55B

V

Value Metrics

Goodwill %iGoodwill/Assets

18.6%

Normal

Goodwill = $21.24B

Total Assets = $114.07B

Working Capital Ratioi

-0.02

Attention

Working Capital = $-1.89B

Total Assets = $114.07B

加载图表中...

Cash Flow Waterfall Chart

加载图表中...

Inflow

Outflow

Subtotal

Start/End

C

Cash Flow Metrics

Operating Cash Flow TTMi

$14.57B

Free Cash Flow TTMi

$10.40B

FCF = OCF - CapEx

OCF (TTM) = $14.57B

CapEx (TTM) = $-4.34B

FCF Yieldi

3.44%

Attention

FCF (TTM) = $10.40B

Market Cap = $302.40B

OCF/Sales Ratioi

24.81%

Healthy

OCF (TTM) = $14.57B

Revenue (TTM) = $58.74B

Q

Quality & Coverage Metrics

Income Qualityi

1.42x

Healthy

OCF (TTM) = $14.57B

Net Income (TTM) = $10.30B

Cash Flow/Debti

0.49x

Normal

OCF (TTM) = $14.57B

Total Debt = $29.62B

Short Term Coveragei

0.48x

Normal

OCF (TTM) = $14.57B

Current Liabilities = $30.62B

Capex Coveragei

3.36x

Healthy

OCF (TTM) = $14.57B

CapEx (TTM) = $4.34B

E

Efficiency Metrics

⚡ Ratios calculated in USD to eliminate exchange rate impact

FCF/OCF Ratioi

71.37%

Normal

FCF (TTM) = $10.40B

OCF (TTM) = $14.57B

Capex/Revenuei

7.38%

Normal

CapEx (TTM) = $4.34B

Revenue (TTM) = $58.74B

Net Debt/EBITDAi

1.21

Normal

Net Debt = $23.91B

EBITDA (TTM) = $19.76B

G

Growth Metrics

OCF Growthi

-19.44%

Attention

Current OCF (TTM) = $2.34B

Previous OCF = $2.91B

Owner Earningsi

$11.73B

Healthy

Net Income (TTM) = $10.30B

+ D&A (TTM) = $5.77B

- CapEx (TTM) = $-4.34B

加载图表中...

Loading...

AstraZeneca PLC

Investment Radar

🔍 Business Model Analysis (DuPont Model)

Leading Indicators

Financial Metrics

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)

EPS (Quarterly)

Gross Profit/Share (Quarterly)

OCF/Share (Quarterly)

FCF/Share (Quarterly)

Operating Leverage (YoY)

💰 Profitability

Gross Margin (TTM)

Operating Margin (TTM)

Net Profit Margin (TTM)

ROE (TTM)

ROA (TTM)

ROTCE - Return on Tangible Common Equity (TTM)

OCF Margin (TTM)

FCF Margin (TTM)

💵 Cash Quality

OCF/NI Ratio (TTM)

FCF/NI Ratio (TTM)

OCF/Capex (TTM)

OCF/SBC (TTM)

🛡️ Leverage & Liquidity

Debt/Equity (quarterly)

EBITDA/Net Debt (TTM)

Interest Coverage (TTM)

Current Ratio (quarterly)

Quick Ratio (quarterly)

Altman Z-Score

⚙️ Ops & Cap Efficiency

ROIC (TTM)

ROCE - Return on Capital Employed (TTM)

Asset Turnover (TTM)

CapEx/Depreciation - Investment Intensity (TTM)

R&D/Gross Profit - R&D Intensity (TTM)

SG&A/Revenue - SG&A Efficiency (TTM)

Cash Conversion Cycle (TTM)

DSO - Days Sales Outstanding (TTM)

DIO - Days Inventory Outstanding (TTM)

DPO - Days Payables Outstanding (TTM)

Goodwill/Assets (Quarterly)

🎁 Shareholder Returns

Dividend Yield (TTM)

Buyback Yield (TTM)

Buyback Yield (3 Years)

Dilution Rate (1 Year)

Dilution Rate (3 Years)

SBC Offset Rate (TTM)

Insider Activity Rate (TTM)

Income Statement Analysis

Profit Waterfall Analysis

Balance Sheet Analysis

Cash Flow Statement Analysis

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)